Cargando…

Correlates of weight gain during long-term risperidone treatment in children and adolescents

BACKGROUND: Most clinical trials of antipsychotics in children are brief, failing to address their long-term safety, particularly when taken concurrently with other psychotropics. This hypothesis-generating analysis evaluates potential correlates of weight gain in children receiving extended risperi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calarge, Chadi Albert, Nicol, Ginger, Xie, Diqiong, Zimmerman, Bridget
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489823/ https://www.ncbi.nlm.nih.gov/pubmed/22643087 http://dx.doi.org/10.1186/1753-2000-6-21

Ejemplares similares

759C/T Variants of the Serotonin (5-HT2C) Receptor Gene and Weight Gain in Children and Adolescents in Long-Term Risperidone Treatment
por: del Castillo, Nicole, et al.
Publicado: (2013)

Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children
por: Bahr, S M, et al.
Publicado: (2015)

Metabolic biomarkers of risperidone-induced weight gain in drug-naïve patients with schizophrenia
por: Qiu, Yuying, et al.
Publicado: (2023)

C677T Polymorphism in the MTHFR Gene Is Associated With Risperidone-Induced Weight Gain in Schizophrenia
por: Liao, Jingping, et al.
Publicado: (2020)

The atypical antipsychotic risperidone targets hypothalamic melanocortin 4 receptors to cause weight gain
por: Li, Li, et al.
Publicado: (2021)

Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents
por: Dos Santos-Júnior, Amilton, et al.
Publicado: (2016)

Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure
por: Bahr, Sarah M., et al.
Publicado: (2015)

The effect of therapeutic drug monitoring of risperidone and aripiprazole on weight gain in children and adolescents: the SPACe 2: STAR (trial) protocol of an international multicentre randomised controlled trial
por: Hermans, Rebecca A., et al.
Publicado: (2022)

An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
por: Pandina, Gahan, et al.
Publicado: (2012)

Risperidone treatment for ADHD in children and adolescents with bipolar disorder
por: Biederman, Joseph, et al.
Publicado: (2008)

Corrigendum to “Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents”
por: Dos Santos-Júnior, Amilton, et al.
Publicado: (2017)

Excessive weight gain after remission of depression in a schizophrenic patient treated with risperidone: case report
por: Theleritis, Christos G, et al.
Publicado: (2006)

The Short-Term Effects of Risperidone-Induced Hyperprolactinemia on Lipid Metabolism in Drug-Naïve Children and Adolescents
por: Park, Eun Jin, et al.
Publicado: (2015)

Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies
por: Nurmi, E L, et al.
Publicado: (2013)

Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia
por: Song, Xueqin, et al.
Publicado: (2014)

Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
por: Canitano, Roberto, et al.
Publicado: (2008)

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
por: Hongkaew, Yaowaluck, et al.
Publicado: (2015)

Risperidone for children and adolescents with autism spectrum disorder: a systematic review
por: Maneeton, Narong, et al.
Publicado: (2018)

Excessive Gestational Weight Gain: Long-Term Consequences for the Child
por: Baran, Joanna, et al.
Publicado: (2020)

The effects of antipsychotic medications on microbiome and weight gain in children and adolescents
por: Bretler, Tali, et al.
Publicado: (2019)

Risperidone long-acting injection: a review of its long term safety and efficacy
por: Rainer, Michael K
Publicado: (2008)

Risperidone Related Raynaud’s Phenomenon: An Adolescent Case
por: Güneş, Serkan, et al.
Publicado: (2018)

Treatment of anorexia nervosa with long-term risperidone in an outpatient setting: case study
por: Kracke, Elsa J, et al.
Publicado: (2014)

CYP2D6 genotype and adverse events to risperidone in children and adolescents
por: Oshikoya, Kazeem A., et al.
Publicado: (2019)

Plasma Risperidone-related Measures in Children and Adolescents with Oppositional Defiant/Conduct Disorders
por: Piacentino, Daria, et al.
Publicado: (2020)

Impact of Pregestational Weight and Weight Gain during Pregnancy on Long-Term Risk for Diseases
por: Moll, Ulrika, et al.
Publicado: (2017)

Exergames to Limit Weight Gain and to Fight Sedentarism in Children and Adolescents with Obesity
por: Calcaterra, Valeria, et al.
Publicado: (2023)

Serum Concentration of Leptin in Pregnant Adolescents Correlated with Gestational Weight Gain, Postpartum Weight Retention and Newborn Weight/Length
por: Sámano, Reyna, et al.
Publicado: (2017)

Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents
por: Margari, Lucia, et al.
Publicado: (2015)

Therapeutic drug monitoring in children and adolescents with schizophrenia and other psychotic disorders using risperidone
por: Taurines, R., et al.
Publicado: (2022)

Risperidone Induced Pisa Syndrome in a Male Adolescent
por: Güneş, Serkan, et al.
Publicado: (2016)

Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study
por: Liu, Haixia, et al.
Publicado: (2022)

Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
por: Hori, Hikaru, et al.
Publicado: (2018)

First known case of catatonia due to cyclosporine A-related neurotoxicity in a pediatric patient with steroid-resistant nephrotic syndrome
por: Heekin, R. David, et al.
Publicado: (2019)

Efficacy and Safety Profile of Risperidone Long-acting Injection in Adolescents in a Real-life Setting
por: Ardic, Ulku Akyol, et al.
Publicado: (2018)

Two cases of life‐threatening arrhythmia induced by risperidone: evaluation of risperidone and 9‐hydroxy‐risperidone concentrations
por: Ito, Asami, et al.
Publicado: (2017)

Modeling the Choice Between Risperidone Long-Acting Injectable and Generic Risperidone from the Perspective of a Japanese Hospital
por: Nakamura, Yusuke, et al.
Publicado: (2019)

Weight gain in childhood and blood lipids in adolescence
por: Horta, Bernardo L, et al.
Publicado: (2009)

Dental biorhythm is associated with adolescent weight gain
por: Mahoney, Patrick, et al.
Publicado: (2022)

RISPERIDONE IN SCHIZOPHRENIA
por: Agashe, Mohan, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_v9imanv3rnj2fqq9fpa6rmf189